https://www.selleckchem.com/MEK.html
742). The mean survival of patients without AKI was higher than that of patients with AKI 1b (591.4 and 305.4 days, respectively, P = 0.015), while there was no significant difference between the mean survival of patients without AKI and that of patients with AKI 1a (591.4 and 373.6 days, respectively, P = 0.198). Only AKI ≥1b seems to substantially impact mortality of patients hospitalized for acute decompensation of cirrhosis. Only AKI ≥1b seems to substantially impact mortality of patients hospitalized for acute decompensation of cirrhosis. Diver